COVID-19 Vaccine Antibody Response in a Single-Center Urban Hemodialysis Unit.

ABSTRACT:

Background

The longitudinal response to the COVID-19 vaccines among patients on hemodialysis with and without prior SARS-CoV-2 infection has not been well characterized.

Methods

To guide vaccination strategies in patients on hemodialysis, it is critical to characterize the longevity and efficacy of the vaccine; therefore, we conducted a prospective single-center monthly antibody surveillance study between March 2021 and March 2022 to investigate the dynamic humoral response to a series of COVID-19 mRNA vaccines in patients on hemodialysis with and without prior SARS-CoV-2 infection. Monthly quantitative antibody testing was performed using the Beckman Coulter Access SARS-CoV-2 IgG Antibody Test©, which detects IgG antibodies targeting the receptor binding domain (RBD) of the

SUBMITTER: He M 

PROVIDER: S-EPMC10384404 | biostudies-literature | 2023 Jul

REPOSITORIES: biostudies-literature